Heron Therapeutics Inc. (HRTX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q2 2023 | |||||
| ≡ | Meridian Contrarian Fund | Sell 100.00% | 1,277,424 | 0.35 | |
| Q4 2022 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 42.05% | 431,000 | 0.20 | |
| Q4 2021 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 6.98% | 52,790 | 0.07 | |
| Q2 2020 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 15.73% | 50,000 | 0.16 | |
| Q1 2020 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 5.92% | 20,000 | 0.06 | |
| Q4 2019 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 20.10% | 85,000 | 0.36 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.